Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Accenture
QuintilesIMS
Boehringer Ingelheim
Teva
Chubb
US Army
Medtronic
Fuji
Fish and Richardson

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072801

« Back to Dashboard
NDA 072801 describes METOCLOPRAMIDE HYDROCHLORIDE, which is a drug marketed by Teva, Ani Pharms, Wockhardt, Hospira, Halsey, Ipca Labs Ltd, Watson Labs, Interpharm, Sandoz, Smith And Nephew, Superpharm, Teva Pharms Usa, Sun Pharm Inds, Roxane, Clonmel, Usl Pharma, Actavis Mid Atlantic, Par Pharm, Bedford, Pharm Assoc, Morton Grove, Impax Labs Inc, Vistapharm, Mutual Pharm, Paco, Northstar Hlthcare, Vintage Pharms, Silarx, Par Pharm Inc, Novel Labs Inc, Fresenius Kabi Usa, Norbrook, Lyphomed, and Schering, and is included in fifty-three NDAs. It is available from forty-six suppliers. Additional details are available on the METOCLOPRAMIDE HYDROCHLORIDE profile page.

The generic ingredient in METOCLOPRAMIDE HYDROCHLORIDE is metoclopramide hydrochloride. There are twelve drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.

Summary for NDA: 072801

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 072801

Mechanism of ActionDopamine D2 Antagonists

Suppliers and Packaging for NDA: 072801

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METOCLOPRAMIDE HYDROCHLORIDE
metoclopramide hydrochloride
TABLET;ORAL 072801 ANDA Teva Pharmaceuticals USA, Inc. 0093-2204 0093-2204-01 100 TABLET in 1 BOTTLE (0093-2204-01)
METOCLOPRAMIDE HYDROCHLORIDE
metoclopramide hydrochloride
TABLET;ORAL 072801 ANDA Teva Pharmaceuticals USA, Inc. 0093-2204 0093-2204-05 500 TABLET in 1 BOTTLE (0093-2204-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE
Approval Date:Jun 15, 1993TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Citi
Accenture
UBS
Fish and Richardson
Johnson and Johnson
Chinese Patent Office
Mallinckrodt
Harvard Business School
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot